DDX3-IN-2

目录号: PL02515 纯度: ≥99%
DDX3-IN-2 是一种活性 DEADbox polypeptide 3 (DDX3) 抑制剂,其 IC50 值 0.3 μM。DDX3-IN-2 表现出广谱的抗病毒活性。DDX3-IN-2 有克服 HIV 耐药的潜力。
CAS No. :1919828-81-1
商品编号 规格 价格 会员价 是否有货 数量
PL02515-5mg 5mg ¥2893.00 请登录
PL02515-10mg 10mg ¥4821.00 请登录
PL02515-25mg 25mg ¥9482.00 请登录
PL02515-50mg 50mg ¥15269.00 请登录
PL02515-100mg 100mg ¥24109.00 请登录
PL02515-200mg 200mg 询价 询价
PL02515-500mg 500mg 询价 询价
PL02515-10mM*1mLinDMSO 10mM*1mLinDMSO ¥3182.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
*注意事项:下单时请联系销售核实产品价格及货期,避免后续产生不便,感谢支持!
中文名称
DDX3-IN-2
英文名称
DDX3-IN-2
英文别名
Urea, N-[4-(4-butyl-1H-1,2,3-triazol-1-yl)phenyl]-N'-(2-methylphenyl)-;DDX3-IN-2
Cas No.
1919828-81-1
分子式
C20H23N5O
分子量
349.43
包装储存
Powder -20°C 3 years;4°C 2 years
详情描述
DDX3-IN-2 是一种活性 DEADbox polypeptide 3 (DDX3) 抑制剂,其 IC50 值 0.3 μM。DDX3-IN-2 表现出广谱的抗病毒活性。DDX3-IN-2 有克服 HIV 耐药的潜力。
产品详情
DDX3-IN-2 是一种活性 DEADbox polypeptide 3 (DDX3) 抑制剂,其 IC50 值 0.3 μM。DDX3-IN-2 表现出广谱的抗病毒活性。DDX3-IN-2 有克服 HIV 耐药的潜力。
生物活性
DDX3-IN-2 is an active DEADbox polypeptide 3 (DDX3) inhibitor with an IC 50 value of 0.3 μM. DDX3-IN-2 shows a broad spectrum of antiviral activity. DDX3-IN-2 has the potential to overcome HIV resistance.
性状
Solid
IC50 & Target[1][2]
HIV
体外研究(In Vitro)
DDX3-IN-2 behaves as a competitive inhibitor with respect to the RNA substrate, which can be seen by the decrease in its inhibition potency as a function of increasing RNA substrate concentrations. DDX3-IN-2 is found to be completely inactive against the ATPase of DDX3, DDX1 helicase, and DENV NS3 helicase. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
DDX3-IN-2 (20 mg/kg; tail vein injection) possesses excellent biocompatibility, and Wistar rats shows a good tolerance to the dose of 20 mg/kg.
DDX3-IN-2 (10 mg/kg; i.v. bolus injection; 0~25 hours) rapidly eliminates the half-life elimination and the plasmatic clearance values. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Brai A, et al. Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents. Proc Natl Acad Sci U S A. 2016;113(19):5388-5393.
溶解度数据
In Vitro: DMSO : 100 mg/mL (286.18 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)
[1]. Brai A, et al. Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents. Proc Natl Acad Sci U S A. 2016;113(19):5388-5393.

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2